Trials / Conditions / Usher Syndrome Type 2
Usher Syndrome Type 2
6 registered clinical trials studyying Usher Syndrome Type 2 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH NCT06627179 | Laboratoires Thea | Phase 2 |
| Terminated | Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon NCT05176717 | Laboratoires Thea | Phase 2 / Phase 3 |
| Terminated | Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in E NCT05158296 | Laboratoires Thea | Phase 2 / Phase 3 |
| Terminated | An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmento NCT05085964 | Laboratoires Thea | Phase 2 |
| Completed | Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the US NCT03780257 | ProQR Therapeutics | Phase 1 / Phase 2 |
| Completed | Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmen NCT01530659 | Neurotech Pharmaceuticals | Phase 2 |